SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported)
September 19,
2001
| Delaware | 1- 2516 | 43-0420020 |
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| 100 Route 206 North, Peapack, New Jersey | 07977 |
| (Address of Principal Executive Offices) |
(Zip Code) |
Item 5. Other Events.
On September 19, 2001, the Registrant announced that its Board of Directors has authorized a stock repurchase program of up to $1 billion over the next two years.
A copy of the press release issued by the Registrant on September 19, 2001 is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
| (c) | Exhibits. The following exhibit is filed as part of this Current Report on Form 8-K: |
|
| 99.1 | Press Release of September 19, 2001. | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| PHARMACIA CORPORATION |
|||
| Dated: September 20, 2001 | By: | /s/ Don W. Schmitz | |
| Name: Title: |
Don W. Schmitz Vice President, Associate General Counsel and Corporate Secretary |
||
INDEX TO EXHIBITS
| Exhibit No. |
Exhibit |
|
| 99.1 | Press Release of September 19, 2001. |
Exhibit 99.1
[PHARMACIA LOGO]
FOR IMMEDIATE RELEASE
Pharmacia Initiates Stock Repurchase Program
PEAPACK, NJ (September 19, 2001) Pharmacia Corporation today announced that its Board of Directors has authorized a stock repurchase program of up to $1 billion over the next two years. The program is effective immediately.
Shares of the Company’s common stock may be repurchased in open market and private transactions. The timing of the transactions and the exact number of shares to be repurchased will be determined by Pharmacia management based on its evaluation of market conditions, share prices and other factors.
As of September 18, 2001, Pharmacia has approximately 1.3 billion shares outstanding.
Pharmacia Corporation (NYSE:PHA) is a top-tier global pharmaceutical company with a leading agricultural subsidiary. Pharmacia’s innovative medicines and other products save lives and enhance health and wellness. Pharmacia’s 59,000 people work together with many diverse stakeholders to bring these benefits to people around the world, and to create new health solutions for the future.
This press release contains forward-looking or anticipatory statements about Pharmacia’s business and financial performance that are based on the information currently available and the expectations currently deemed reasonable by Pharmacia. However, because these forward-looking statements are subject to many risks, uncertainties and changes over time, including those referenced in Pharmacia’s filings with the U.S. Securities and Exchange Commission, actual results may differ materially from those expressed or implied by these forward-looking statements. Pharmacia undertakes no obligation to update any forward-looking statements as a result of new information or future developments.
###
|
Media Contact: Paul Fitzhenry (908) 901-8770 |
Analyst Contact: Craig Tooman (908) 901-8853 |